Search research articles
Contact Us
Filters
Showing results (881-890 of 1,088) with videos related to
Page
of 109
Sort By:
JCO Precision Oncology
|
October 6, 2022
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With <i>ALK</i>/<i>ROS1</i>/<i>RET</i>-Rearranged Lung Cancers
Harper Hubbeling, Noura Choudhury, Jessica Flynn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
Michael Offin, Narek Shaverdian, Andreas Rimner, et al.
Hospital Pediatrics
|
September 2, 2025
Site-Specific Adaptation of an Inpatient Patient Navigator Program at 2 Children's Hospitals
Dean J Karavite, Brian O Vazquez, Citlali R Gomez Acosta, et al.
Journal of the National Cancer Institute
|
September 10, 2024
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers
Alexander G Goglia, Mohammed Alshalalfa, Anwar Khan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 10, 2025
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic Radiosurgery
Benjamin Gaeta, Jordan E Eichholz, Henry Walch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTEND
Alexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
American Journal of Obstetrics & Gynecology MFM
|
August 20, 2025
Maternal, fetal, and neonatal serious adverse events associated with low-dose aspirin during the first trimester of pregnancy: A secondary analysis of the ASPIRIN trial
Maria J Rodriguez-Sibaja, Natalia Galvez-Rubalcava, Gonzalo Hagerman-Sucar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 23, 2018
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer
Chonnipa Nantavithya, Daniel R Gomez, Xiong Wei, et al.
Physics and Imaging in Radiation Oncology
|
October 15, 2025
Prospective validation of a pretreatment 18F-FDG PET/CT and mean lung dose model for early radiation pneumonitis
Maria Thor, Aditya Apte, Milan Grkovski, et al.
Head & Neck
|
March 31, 2016
Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis
Evan S Wu, Jong Y Park, Joseph A Zeitouni, et al.
Page
of 109
Search research articles
Search
Showing results (881-890 of 1,088) with videos related to
Sort By:
Page
of 109
JCO Precision Oncology
|
October 6, 2022
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With <i>ALK</i>/<i>ROS1</i>/<i>RET</i>-Rearranged Lung Cancers
Harper Hubbeling, Noura Choudhury, Jessica Flynn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
Michael Offin, Narek Shaverdian, Andreas Rimner, et al.
Hospital Pediatrics
|
September 2, 2025
Site-Specific Adaptation of an Inpatient Patient Navigator Program at 2 Children's Hospitals
Dean J Karavite, Brian O Vazquez, Citlali R Gomez Acosta, et al.
Journal of the National Cancer Institute
|
September 10, 2024
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers
Alexander G Goglia, Mohammed Alshalalfa, Anwar Khan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 10, 2025
Intracranial Disease Control and Survival among Patients with KRAS-mutant Lung Adenocarcinoma and Brain Metastases Treated with Stereotactic Radiosurgery
Benjamin Gaeta, Jordan E Eichholz, Henry Walch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTEND
Alexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
American Journal of Obstetrics & Gynecology MFM
|
August 20, 2025
Maternal, fetal, and neonatal serious adverse events associated with low-dose aspirin during the first trimester of pregnancy: A secondary analysis of the ASPIRIN trial
Maria J Rodriguez-Sibaja, Natalia Galvez-Rubalcava, Gonzalo Hagerman-Sucar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 23, 2018
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer
Chonnipa Nantavithya, Daniel R Gomez, Xiong Wei, et al.
Physics and Imaging in Radiation Oncology
|
October 15, 2025
Prospective validation of a pretreatment 18F-FDG PET/CT and mean lung dose model for early radiation pneumonitis
Maria Thor, Aditya Apte, Milan Grkovski, et al.
Head & Neck
|
March 31, 2016
Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis
Evan S Wu, Jong Y Park, Joseph A Zeitouni, et al.
Page
of 109